Markets › Stocks › AUROLAB
AU

Auro Laboratories Ltd

NSE: AUROLABBSE: 530233Healthcare
₹262.85
▼ -0.02%
NSE · 15-min delayed
Mkt Cap
₹173 Cr
P / E
47.5
P / B
3.7
ROE
7.6%
52W High
₹317.00
52W Low
₹159.00
Key Metrics
Market Cap
₹173 Cr
P / E
47.5
P / B
3.7
ROCE
8.3%
ROE
7.6%
Div Yield
-
Revenue · ₹ Cr
44
FY20
54
FY21
51
FY22
53
FY23
54
FY24
19
FY25
31
FY26
Net Profit · ₹ Cr
4
FY20
7
FY21
3
FY22
2
FY23
8
FY24
2
FY25
4
FY26
EPS · ₹ per share
₹13.0
FY20
₹11.5
FY21
₹4.6
FY22
₹3.9
FY23
₹12.5
FY24
₹3.0
FY25
₹5.7
FY26
Q1 2026 snapshot
Sales
₹11 Cr
Operating profit
-
OPM
-
Net profit
₹1 Cr
EPS
₹1.56
Scorecard · 7 axes
Quality
Weak
40/100
Valuation
Weak
47.5×
Growth
Bad
-3.1%
Profitability
Weak
7.9%
Performance
Bad
-5.0%
Entry Point
Avg
83%
Red Flags
Strong
0 flags
Shareholding Pattern
52.2%Promoter
Promoter52.2%
DII0.0%
Public47.8%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue3.27.533.199.819.5710.5
Net Profit0.0510.394-0.1050.7161.9520.971
NPM %1.6%5.2%-3.3%7.3%20.4%9.2%
AlertPre-trade